GlobeNewswire Inc.··NaTenax Therapeutics Appoints Seasoned Pharma Executive Timothy Healey as CCO
Tenax Therapeutics appoints veteran pharma executive Timothy Healey as Chief Commercial Officer to lead TNX-103 market launch preparations as Phase 3 trials advance.
TENXPhase 3 clinical trialcommercial strategy